The dry eye syndrome is triggered by an insufficient tear film production or a change in its composition. An eye doctor is needed to determine the underlying cause. In severe cases, dry eyes can lead to a considerable impairment of the quality of life as the disease is accompanied by symptoms such as very red and consistently painful eyes.
High viscosity improves the quality of life
The treatment of severe, chronic dry eyes has to ensure an intensive and lasting lubrication of the ocular surface. Only highly viscous eye drops, that therefore remain for considerably longer on the ocular surface, can guarantee a long-lasting lubrication. The extraordinarily high quality sodium hyaluronate used in HYLO® GEL is perfectly suited for this task. Combined with the distinct properties of the substance a concentration of 0.2 % suffices to obtain eye drops with an outstanding high viscosity. However, despite HYLO® GEL’s almost gel-like consistency it does not cause impairment of vision.
Preservative and phosphate free in the patented COMOD® device
Preservatives, which are designed to prevent contamination of eye drops during storage and use, can affect the natural tear film and damage the cells of the ocular surface. Furthermore, they can cause intolerance reactions¹. Modern ocular lubricants are therefore preservative free. This also applies to HYLO® GEL as it is provided in the patented COMOD® multi-dose device that, in a unique way, prevents contamination of its contents.
Phosphates that are widely used in eye drops can also have a harmful effect on an already damaged cornea². The binding of phosphate to calcium, which is released from damaged corneal cells, may lead to the formation of sparingly soluble calcifications that can permanently impair vision. Therefore, eye drops used on a dry and damaged ocular surface should not contain phosphates. HYLO® GEL is phosphate free and therefore presents no risk of corneal calcification.
The benefits of HYLO® GEL lubricating eye drops
HYLO® GEL lubricating eye drops have been developed for the special requirements of chronically dry eyes and for particularly severe cases of dry eyes.
The benefits of HYLO® GEL at a glance:
Intensive and long-lasting eye lubrication due to 0.2% hyaluronan for severe and sustained symptoms of dry eyes
Supports the regeneration of the surface of the eye after operations - post-operative
Prescription-free yet can be prescribed in cases of damage to the lacrimal gland, various autoimmune diseases, inability to close the eyelids completely (lagophthalmos) and facial nerve paralysis
HYLO® GEL eye drops provide intensive and long-lasting lubrication for severe cases of dry eyes. The drops have a highly viscous consistency and are therefore ideal for the special needs of severe and chronic eye symptoms. In addition, they are outstandingly well-suited to supporting the healing of eyes following an operation.
HYLO® GEL lubricating eye drops can be prescribed for some diseases because of their therapeutic properties. In these cases, they can be prescribed by the doctor and the costs can be paid by health insurance funds. HYLO® GEL eye drops contain the ingredient hyaluronan and are free from preservatives and phosphates. That is why HYLO® GEL lubricating eye drops have very good tolerability.
HYLO® GEL eye drops: for severe and chronic cases of dry eyes
Anyone who suffers constantly from severe symptoms of dry eyes often feels that his/her whole quality of life has been affected. This is hardly surprising, as the symptoms can be accompanied not only by unsightly redness, but also by a scratching, burning or painful foreign body sensation in the eye.
The reason for this is usually insufficient production of lacrimal fluid. But also when the tear film has a disrupted composition, it can lead to the normal lubrication of the surface of the eye no longer being possible. The eyes start to water and yet are not protected against drying out and irritation.
Defective or insufficient lubrication of the eye can lead to drying out and damage of the cornea and increase the risk of infection. HYLO® GEL lubricating eye drops are an effective means of relieving the symptoms and avoiding possible secondary diseases.
It is also possible that the production of tears is hindered or disrupted after eye surgery, like in the treatment of glaucoma or cataracts. In such cases, it is particularly important to have good eye lubrication for the healing and regeneration of the surface of the eye. HYLO® GEL eye drops are also ideal in this case for supporting the natural tear film.
Intensive lubrication, long-lasting effect, good tolerability
The viscous and good adherence properties of HYLO® GEL lubricating eye drops make them special. They facilitate long-lasting contact of the film of fluid with the surface of the eye. The eyelids can close smoothly without irritation occurring again and without the tears being washed away.
The elastic consistency of HYLO® GEL lubricating eye drops is due to the special properties of the hyaluronan used. Hyaluronan is a substance which is naturally present in the eye and other areas of the body, for example as a main component of joint fluid, and it is therefore very well tolerated. Despite their gel-like consistency, HYLO® GEL eye drops do not impair vision and they can even be used at the same time as contact lenses. Like all products from the HYLO EYE CARE® range, HYLO® GEL eye drops are free from preservatives and phosphates and therefore are well tolerated.
HYLO® GEL: High viscosity for severe dry eyes
Eye drops containing 0.2 % sodium hyaluronate provided in the COMOD®device
Noticeable more viscous eye drops that guarantee long-lasting lubrication without impairing vision
Unique in its efficacy and without therapeutic alternative
Unique effectiveness without therapeutic alternative
Preservative and phosphate free
Compatible with contact lenses
HYLO® GEL: Unique in its efficacy and safety profile, officially confirmed in Germany!³
¹ Report of the international Dry Eye Workshop (DEWS); The Ocular Surface, 2007 (5); No.2 ² BfArM & PEI Bulletin zurArzneimittelsicherheit (Bulletin for Drug Safety) 2013; 1: 7-12 ³ German Federal Joint Committee (G-BA): Annex V to section J of the guidelines on the prescription of drugs